Skip to main content
Tech.euFundingExplorerBeta

Criteria Bio Ventures

Investor profile

Venture capital

Criteria Bio Ventures has backed 2 European tech companies across 2 funding rounds in 2025, joining rounds totalling €61M. Most active in Healthtech. Data as of Nov 2026.

Deals
2
distinct rounds
Companies
2
backed
Active span
2025
1 yr
Total round €
€61M
sum of rounds joined

Deals by year

distinct rounds / year
Criteria Bio Ventures — deals by year — interactive chart.
Data table
Criteria Bio Ventures — deals by year
20252

Top sectors

by deals
Criteria Bio Ventures — top sectors — interactive chart.
Data table
Criteria Bio Ventures — top sectors
Healthtech2

Stages

by deals
Criteria Bio Ventures — stages — interactive chart.
Data table
Criteria Bio Ventures — stages
Pre-Seed1
Series B1

Countries

by deals
Criteria Bio Ventures — countries — interactive chart.
Data table
Criteria Bio Ventures — countries
Spain1
UK1

Co-investment network

shared rounds
Co-investment network — interactive chart.
Criteria Bio Ventures — 2 dealsCriteria Bio VenturesBrandon Capital — 1 shared deals · click to openBrandon CapitalBritish Business Bank — 1 shared deals · click to openBritish Business BankM Ventures — 1 shared deals · click to openM VenturesNovartis Venture Fund — 1 shared deals · click to openNovartis Venture FundOmega Funds — 1 shared deals · click to openOmega FundsSV Health Investors’ Dementia Discovery Fund (DDF) — 1 shared deals · click to openSV Health Investors’ Dementia Discovery Fund (DDF)

Hover a node for shared-deal counts; click a co-investor to open its profile.

Best viewed on a larger screen.

Portfolio

top 30 by total round €
CompanyCountryRoundsTotal €
NRG TherapeuticsUK1€58M
Adaptam TherapeuticsSpain1€3.0M

Biggest deals

top 10 by amount
CompanyStageAmountDate
NRG TherapeuticsSeries B€58M2025-09
Adaptam TherapeuticsPre-Seed€3.0M2025-10
← Back to investors